Figure 2From: Renal protection in diabetes: lessons from ONTARGET®Effects of treatment with telmisartan 80 mg or losartan 100 mg on urinary protein/creatinine ratio (UPCR) in patients with type 2 diabetes and overt nephropathy (morning spot UPCR ≥ 700 mg/g creatinine) [70].Back to article page